Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2484-2488

  Palmer, Kirsten ^a,b   Saglam, Burcu ^a   Whitehead, Clare ^a,b   Stock, Owen ^a   Lappas, Martha ^b   Tong, Stephen ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECLAMPTIC SEIZURE; FEMALE; GENE EXPRESSION; HELLP SYNDROME; HUMAN; HUMAN TISSUE; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIOTROPHOBLAST; WESTERN BLOTTING;

EID: 79959377658     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.029     Document Type: Article

References (22)

1. Sibai BM, Caritis S, Hauth J: What we have learned about preeclampsia. Semin Perinatol 2003, 27:239-246 (Pubitemid 36828961)
2. Walker JJ: Pre-eclampsia. Lancet 2000, 356:1260-1265
3. Brosens I: Morphological changes in the uteroplacental bed in pregnancy hypertension. Clin Obstet Gynecol 1977, 4:573-593 (Pubitemid 8234457)
4. Roberts JC, Cooper DW: Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56 (Pubitemid 32056505)
5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658 (Pubitemid 36278583)
6. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649 (Pubitemid 43865232)
7. Silasi M, Cohen B, Karumanchi SA, Rana S: Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 2010, 37:239-253
8. Mutter WP, Karumanchi SA: Molecular mechanisms of preeclampsia. Microvasc Res 2008, 75:1-8 (Pubitemid 350266733)
9. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006, 355:992-1005 (Pubitemid 44343543)
10. Steinberg G, Khankin EV, Karumanchi SA: Angiogenic factors and preeclampsia. Thromb Res 2009, 123(Suppl 2):S93-S99
11. Kanasaki KPK, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH Jr, Folkman J, Strauss JF, Kalluri R: Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008, 453:1117-1121 (Pubitemid 351871733)
12. Li H, Gu B, Zhang Y, Lewis DF, Wang Y: Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005, 26:210-217 (Pubitemid 40247009)
13. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Carniggia I: Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006, 291:R1085-R1093 (Pubitemid 44498450)
14. Thomas CP, Andrews JI, Raikwar NS, Kelley EA, Herse F, Dechend R, Golos TG, Liu KZ: A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J Clin Endocrinol Metab 2009, 94:2524-2530
15. Kang SH, Cho HT, Devi S, Zhang Z, Escuin D, Liang Z, Mao H, Brat DJ, Olson JJ, Simons JW, Lavallee TM, Giannakakou P, Van Meir EG, Shim H: Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model. Cancer Res 2006, 66:11991-11997 (Pubitemid 46094213)
16. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P: 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003, 3:363-375 (Pubitemid 38340305)
17. Lee SB, Wong AP, Kanasaki K, Xu Y, Shenoy VK, McElrath TF, Whitesides GM, Kalluri R: Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol 2010, 176:710-720
18. ACOG Committee on Practice Bulletins-Obstetrics: ACOG Practice bulletin No. 33: diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002, 99:159-167
19. Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA: Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol 2006, 194:1034-1041
20. Jauniaux E, Poston L, Burton GJ: Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006, 12:747-755 (Pubitemid 44605512)
21. Rajakumar A, Brandon HM, Daftary A, Ness R, Conrad KP: Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004, 25:763-769 (Pubitemid 39276941)
22. Tal R, Shaish A, Barshack I, Polak-Charcon S, Afek A, Volkov A, Feldman B, Avivi C, Harats D: Effects of hypoxia-inducible factor- 1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction. Am J Pathol 2010, 177:2950-2962